Spatial Metabolomics and Imaging Mass Spectrometry in the Age of Artificial Intelligence

Posted: 31 Jul 2020

See all articles by Theodore Alexandrov

Theodore Alexandrov

European Molecular Biology Laboratory (EMBL) - Germany - Structural and Computational Biology Unit

Date Written: July 2020

Abstract

Spatial metabolomics is an emerging field of omics research that has enabled localizing metabolites, lipids, and drugs in tissue sections, a feat considered impossible just two decades ago. Spatial metabolomics and its enabling technology—imaging mass spectrometry—generate big hyperspectral imaging data that have motivated the development of tailored computational methods at the intersection of computational metabolomics and image analysis. Experimental and computational developments have recently opened doors to applications of spatial metabolomics in life sciences and biomedicine. At the same time, these advances have coincided with a rapid evolution in machine learning, deep learning, and artificial intelligence, which are transforming our everyday life and promise to revolutionize biology and healthcare. Here, we introduce spatial metabolomics through the eyes of a computational scientist, review the outstanding challenges, provide a look into the future, and discuss opportunities granted by the ongoing convergence of human and artificial intelligence.

Suggested Citation

Alexandrov, Theodore, Spatial Metabolomics and Imaging Mass Spectrometry in the Age of Artificial Intelligence (July 2020). Annual Review of Biomedical Data Science, Vol. 3, pp. 61-87, 2020, Available at SSRN: https://ssrn.com/abstract=3658948 or http://dx.doi.org/10.1146/annurev-biodatasci-011420-031537

Theodore Alexandrov (Contact Author)

European Molecular Biology Laboratory (EMBL) - Germany - Structural and Computational Biology Unit ( email )

Heidelberg, 69117
Germany

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
556
PlumX Metrics